K-numberK260455
Device nameNew Wave System
ApplicantZeto, Inc.
Product codeGWQ
Device classClass II
Decision dateMar 13, 2026
DecisionSubstantially Equivalent
Regulation882.1400
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The New Wave System is an electroencephalograph (EEG) device intended for prescription use in outpatient healthcare facilities or home settings to acquire, transmit, display, and store EEG and optional auxiliary signals (ECG, EOG, EMG, orientation sensor data, photic sensor data, external trigger signals, and video) for adults and children, excluding newborns. The device is limited to short-term recordings up to 2.5 hours and uses 19 EEG electrodes plus up to 8 auxiliary inputs.

Technological characteristics

The New Wave shares identical core EEG acquisition performance with the predicate Flexset System: 19-channel electrode configuration, 500 Hz sampling rate, 24-bit A/D conversion, approximately 1 μV RMS noise, active dry Ag/AgCl electrodes, flexible semi-rigid headset architecture, and wireless communication (Wi-Fi and LTE). Minor differences include a higher capacity 5000 mAh battery (versus 3950 mAh) supporting 2.5-hour operation, a commercial-grade charger instead of medical-grade, upgraded 5G Hz LTE capability, and reduced internal storage (25 hours versus 250 hours), all appropriate for the narrower intended use.

Test standards cited

IEC 60601-1 (medical device safety requirements) is cited as the internal safety standard. ISO 13485 clauses 7.3, 8.3, 8.5.2, 8.5.3, and 4.2.3 are referenced for quality management system requirements. The 10-20 EEG system standard is mentioned for electrode positioning compliance.

Substantial equivalence argument

The New Wave is substantially equivalent to the predicate Flexset System (K233403) because both devices share identical technological characteristics, signal acquisition performance, and clinical functionality for EEG measurement. The only differences are a narrower intended use environment (home and outpatient healthcare facilities only versus broader healthcare/transport settings) and reduced recording duration (2.5 hours versus 6-7 hours), which represent a subset of the predicate's approved scope and do not introduce new safety or effectiveness questions. No software validation or clinical testing was required because the firmware and software are materially unchanged from the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →